Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

Oncolix Inc. (AEPP)

Add AEPP Price Alert      Hide Sticky   Hide Intro
Moderator: zen222, reaper247, BW, Rat Fink, ninersax, BLight1911
Search This Board: 
Last Post: 11/19/2017 4:37:37 PM - Followers: 165 - Board type: Free - Posts Today: 6

A pharmaceutical company in Harris County, Texas.

14405 Walters Rd, Houston, TX 77014
(281) 402-3168
Contact Us

Oncolix, Inc. (Oncolix) is a clinical-stage biotechnology company

We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer.  This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat. Prolanta™ is a prolactin receptor antagonist that has demonstrated significant efficacy in xenograft models through a unique mechanism of action, autophagy (see Our Science). In addition to ovarian cancer, there is strong preclinical evidence Prolanta™ will be effective in breast, prostate and other cancers.

The FDA has also approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer, which may allow reduced filing fees, federal tax credits and marketing exclusivity by the FDA.

Proudly partnered with Greenville Health System

Oncolix, Inc. (Oncolix) is a bio-pharmaceutical company originally established at the Greenville Health System through the innovative efforts of the Oncology Research Institute in conjunction with the GHS Cancer Center drug discovery program. Oncolix, now based in Houston, Texas, is currently focusing on phase one clinical trials of Prolanta™ - a targeted therapeutic protein for the treatment of breast and ovarian cancer. Prolanta™ was pioneered within the Oncology Research Institute (now known as the Clemson Biomedical Institute) at GHS in Greenville, SC.

Proudly partnered with MD Anderson Cancer Treatment Center

MD Anderson has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.


Oncolix patents

Oncolix has 30 patents in their patent portfolio, including 8 U.S patents.


AEPP Security Details
Share Structure
  Market Value1 $3,571,704 a/o Apr 07, 2017
Authorized Shares 500,000,000 a/o Mar 30, 2017
Outstanding Shares 93,911,633 a/o Apr 04, 2017
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 33,311,633 a/o Apr 06, 2017
  Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 101 a/o Apr 06, 2017

As per OTC markets. Updates are pending

Who is Oncolix, Inc.?

April 2017 Company Presentation:


Early funding for Prolactin research was granted from the Susan G. Komen foundation and the U.S government.
More recent funding came from accredited investment including TEXAS TREASURY SAFEKEEPING TRUST CO and the Ernest Mario Family Trust.
Ernest Mario is an American pharmaceutical industry executive and the recipient of the 2007 Remington Honor Medal awarded by the American Pharmacists Association.



Ernest Mario is the former CEO of GlaxoSmithKilne NYSE: GSK.

He is also Rutgers University alumni who has had the Rutgers School of Pharmacy named after him.

Potential revenue moving forward.



The Oncolix Team




Board Members




Company Advisors






This space reserved for updates.



Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AEPP News: Securities Registration Statement (s-1/a) 11/14/2017 06:32:52 AM
AEPP News: Amended Current Report Filing (8-k/a) 11/14/2017 06:11:33 AM
AEPP News: Amended Current Report Filing (8-k/a) 10/26/2017 06:05:36 AM
AEPP News: Securities Registration Statement (s-1/a) 10/24/2017 04:52:10 PM
AEPP News: Quarterly Report (10-q) 10/23/2017 06:05:50 AM
#13198  Sticky Note Alright, lets review what most people already seem reaper247 11/09/17 12:08:37 AM
#13017  Sticky Note Must see interview from Oncolix CEO Michael Redman. reaper247 11/04/17 12:53:27 AM
#12638  Sticky Note Email response from Michael Redman: Dear Joshua, Thank you arbytrader 10/24/17 07:50:30 AM
#12063  Sticky Note Presentation Recap microcaptrdr24 10/05/17 06:14:18 PM
#11604  Sticky Note Massive dilution is just around the corner......... DayDreeming 09/18/17 03:39:45 PM
#13590   M.D. ANDERSON'S PRE-CLINCAL TRIAL "ONCOLIX" PROLANTA (G129R) Rat Fink 11/19/17 04:37:36 PM
#13588   I think that you have raised a good tmcfo 11/19/17 10:47:41 AM
#13587   Oncolix's first 3 patients were dosed 28 days, namtae 11/19/17 10:04:50 AM
#13586   I think stage 1b is only 28 days. Sungod95 11/19/17 09:00:59 AM
#13585   Wonder if/when these trials will start again and namtae 11/19/17 08:27:45 AM
#13581   You didn't know about the 3 person stock test? dabullishbear 11/18/17 09:43:03 PM
#13580   3 people testing a stock? What are you BLight1911 11/18/17 08:12:21 PM
#13579   More to come but this stock is about Airstock 11/18/17 08:00:05 PM
#13578   I do think in a strategic partnership path Eltp 11/18/17 06:06:14 PM
#13577   AEPP/"ONCOLIX" HAS 8 U.S. PATENTS IN U.S. AND_MANY)_PATENTS_IN_OTHER_COUN Rat Fink 11/18/17 04:41:02 PM
#13575   I've been wondering something similar...Either the FINRA bureaucratic AltJactUp 11/18/17 01:32:22 PM
#13574   You don't have to be a chartist to zen222 11/18/17 01:15:15 PM
#13573   AEPP/ONCOLIX: "PREPARING TO UPLIST FROM PINK_SHEETS_TO_OTC-QB..."!!!_https://inv Rat Fink 11/18/17 01:03:08 PM
#13572   AEPP/ONCOLIX, "SUBSTANTIAL NEWS FLOW IN COMING_MONTHS"!!!_https://investorshub.a Rat Fink 11/18/17 01:02:43 PM
#13571   Does anyone think that AEPP is going to Heyhey44 11/18/17 12:49:27 PM
#13570   SCAM ALERT ON AEPP... CHART LOOKS TERRIBLE.... Airstock 11/18/17 11:36:42 AM
#13568   Sorry, not a stock trading pro but I namtae 11/18/17 08:51:25 AM
#13566   Well, imagine my excitement at a learning opportunity, reaper247 11/17/17 11:40:10 PM
#13564   IMPRESSIVE 4/24/17_AEPP/ONCOLIX_CEO_INTERVIEW: Rat Fink 11/17/17 10:33:34 PM
#13560   I'm not expecting full completion of phase 1 CatfishHunter 11/17/17 06:18:51 PM
#13559   that is how I've tended to see things Bored Lawyer 11/17/17 05:54:39 PM
#13558   The huge catalyst and run up will come CatfishHunter 11/17/17 05:34:02 PM
#13557   Well if you're day trading or swing trading, dabullishbear 11/17/17 05:08:03 PM
#13556   You may be correct namtae 11/17/17 05:00:24 PM
#13555   The increase in the AS is a smart tmcfo 11/17/17 04:58:03 PM
#13554   Correct. With positive trial results as a catalyst, zen222 11/17/17 04:45:28 PM
#13553   Not worried because if they are able to dabullishbear 11/17/17 04:27:13 PM
#13552   Yeah but in the scope of things is maro1 11/17/17 04:26:10 PM
#13551   An increase in authorized usually signals a company namtae 11/17/17 04:15:44 PM
#13550   Authorized shares do not hit the market until dabullishbear 11/17/17 03:40:34 PM
#13549   Yeah but it's pretty hard to hide a dabullishbear 11/17/17 03:36:42 PM
#13548   Whatever the paid promotion is, its not doing namtae 11/17/17 03:32:57 PM
#13547   I could be wrong, but as you move dabullishbear 11/17/17 03:32:05 PM
#13546   Not to mention the additional 450 million shares laraz5 11/17/17 03:31:36 PM
#13545   Generally speaking, the SEC cant handle its current namtae 11/17/17 03:31:03 PM
#13544   Stocks in the OTC go from 'zero interest' dabullishbear 11/17/17 03:29:26 PM
#13543   Stick around and we'll all find out together. zen222 11/17/17 03:28:38 PM
#13542   Only about $2k in dollar volume traded so namtae 11/17/17 03:24:57 PM
#13541   And you really think that MTR and JDP dabullishbear 11/17/17 03:24:41 PM
#13540   And by the way, AEPP is no longer dabullishbear 11/17/17 03:19:52 PM
#13538   That is pure fantasy mixed with ridiculous misinformation. zen222 11/17/17 02:42:01 PM
#13537   The highlighted Lies coming out of this Company laraz5 11/17/17 02:37:20 PM
#13536   So why didnt you reply back to Reapers Sungod95 11/17/17 02:05:11 PM
#13535  Restored So when new investors obtain inaccurate information about namtae 11/17/17 01:37:49 PM
#13534   No reason to remove the sticky. Reaper CatfishHunter 11/17/17 12:37:56 PM
#13533   Only the person who stickied the post can BLight1911 11/17/17 12:31:47 PM
#13532   Soooo next week? steadyhand 11/17/17 12:13:29 PM